Cabaletta Bio CABA
NASDAQ CABA
$3.46 -0.02 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

Cabaletta Bio (CABA) Profit After Tax (2018 - 2026)

Cabaletta Bio (CABA) posted quarterly Profit After Tax of -$41.9 million for Q4 2025, down 28.63% year-over-year from -$58.7 million in Q4 2024, and up 6.57% quarter-over-quarter from -$44.9 million in Q3 2025.

Analysis

Cabaletta Bio (CABA) Profit After Tax (2018 - 2026) Analysis & Trends

Cabaletta Bio's Profit After Tax history runs 8 years deep, the most recent figure standing at -$41.9 million for Q4 2025.

  • In Q4 2025, Profit After Tax fell 28.63% year-over-year to -$41.9 million; the TTM figure through Dec 2025 stood at -$167.9 million (down 44.91% YoY), while the FY2025 annual figure was -$167.8 million, down 44.8% from the prior year.
  • Profit After Tax for Q4 2025 stood at -$41.9 million, up from -$44.9 million in the prior quarter.
  • The five-year high for Profit After Tax was -$9.7 million in Q1 2021, with the low at -$45.1 million in Q2 2025.
  • The 5-year median for Profit After Tax is -$16.2 million (2023), against an average of -$22.5 million.
  • The sharpest annual moves came in 2022 and 2024: Profit After Tax increased 1.16% in 2022, then slumped 90.53% in 2024.
  • Cabaletta Bio's Profit After Tax stood at -$13.9 million in 2021, then declined by 13.38% to -$15.7 million in 2022, then slumped by 32.02% to -$20.8 million in 2023, then sank by 56.83% to -$32.6 million in 2024, then dropped by 28.63% to -$41.9 million in 2025.
  • Business Quant data shows CABA's Profit After Tax at -$41.9 million in Q4 2025, -$44.9 million in Q3 2025, and -$45.1 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -16.62 Mn
10 Cabaletta Bio 522.26 Mn 522.26 Mn - -51.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -51.02 Mn
Dec 31, 2025 -41.92 Mn
Sep 30, 2025 -44.87 Mn
Jun 30, 2025 -45.13 Mn
Mar 31, 2025 -35.94 Mn
Dec 31, 2024 -32.59 Mn
Sep 30, 2024 -30.63 Mn
Jun 30, 2024 -27.60 Mn
Mar 31, 2024 -25.05 Mn
Dec 31, 2023 -20.87 Mn
Sep 30, 2023 -16.47 Mn
Jun 30, 2023 -14.49 Mn
Mar 31, 2023 -15.85 Mn
Dec 31, 2022 -15.53 Mn
Sep 30, 2022 -11.43 Mn
Jun 30, 2022 -12.91 Mn
Mar 31, 2022 -12.95 Mn
Dec 31, 2021 -13.88 Mn
Sep 30, 2021 -11.56 Mn
Jun 30, 2021 -11.14 Mn